MiR-1 downregulation plays a critical role in the angiogenic response and tumor progression, and endothelial-specific overexpression of miR-1 in the lung inhibits KRAS mutant-P53 knockout (KP) tumor formation by more than 90%21. The gene discussed is KRAS; the disease is neoplasm.